Internal profit and loss account
| Internal profit and loss account | 1.1.–31.12.2023 | 1.1.–31.12.2022 |
|---|---|---|
| NET TURNOVER | 57 400 907,56 | 53 438 443,99 |
| Variation in stocks of finished goods and in work in progress | -19 355,00 | 96 452,00 |
| Other operational income | 1 764 499,02 | 3 563 110,94 |
| Raw materials and services | ||
| Raw materials and consumables | ||
| Purchases during the financial year | 11 433 116,81 | 12 472 467,59 |
| Variation in stocks | 175 879,00 | -491 993,00 |
| External services | 2 569 088,18 | 1 989 528,62 |
| Raw materials and services, total | 14 178 083,99 | 13 970 003,21 |
| Staff expenses | ||
| Wages and salaries | 22 672 846,05 | 21 938 244,25 |
| Social security expenses | ||
| Pension expenses | 4 056 622,62 | 3 929 331,32 |
| Other social security expenses | 841 159,79 | 786 798,45 |
| Staff expenses, total | 27 570 628,46 | 26 654 374,02 |
| Depreciation, amortisation and reduction in value | ||
| Depreciation and amortisation according to plan | 3 542 652,82 | 2 745 823,04 |
| Other operating expenses | 17 921 707,25 | 21 428 598,28 |
| OPERATING PROFIT/LOSS | -4 067 020,94 | -7 700 791,62 |
| Financial income and expenses | ||
| Interest income and other financial income | 1 265 941,70 | 835 109,72 |
| Interest and other financial expenses | -169 127,24 | -3 148 668,18 |
| Financial income and expenses, total | 1 096 814,46 | -2 313 558,46 |
| Change in value | 3 507 897,68 | -2 454 011,16 |
| PROFIT/LOSS BEFORE APPROPRIATIONS | 537 691,20 | -12 468 361,24 |
| Taxes | ||
| Blood Service Research Fund | -497 248,86 | -500 000,00 |
| PROFIT/LOSS FOR THE FINANCIAL YEAR (internal) | 40 442,34 | -12 968 361,24 |